Time away from normal activities (days) · paediatric and adult patients with appendiceal phlegmon
It is very uncertain whether early changes time away from normal activities (days) Median compared with delayed open or laparoscopic appendicectomy (very low certainty).
1 finding from 1 review
Neonatal mortality · neonates born from 35 weeks of gestation who have underdone gastrointestinal surgery
1 finding from 1 review
Age at full enteral feedings (days) · neonates born from 35 weeks of gestation who have underdone gastrointestinal surgery
1 finding from 1 review
Use of coercive measure: use of seclusion room (time, days) · aggressive behaviour in schizophrenia
Structured risk assessment showed no clear difference in use of coercive measure: use of seclusion room (time, days) compared with standard professional care (low certainty).
1 finding from 1 review
Time to achieve full enteral feeding (days) · preterm infants
1 finding from 1 review
Patency at 30 days · thrombosed haemodialysis arteriovenous fistulas and grafts
It is very uncertain whether surgical thrombectomy changes patency at 30 days compared with pulse spray technique (very low certainty).
1 finding from 1 review
Patency at 30 days · thrombosed haemodialysis arteriovenous fistulas and grafts
It is very uncertain whether mechanical thrombectomy changes patency at 30 days compared with pulse spray technique (very low certainty).
1 finding from 1 review
Patency at 30 days · thrombosed haemodialysis arteriovenous fistulas and grafts
It is very uncertain whether mechanical thrombectomy changes patency at 30 days compared with continuous infusion (very low certainty).
1 finding from 1 review
Patency at 30 days · thrombosed haemodialysis arteriovenous fistulas and grafts
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Patency at 30 days · thrombosed haemodialysis arteriovenous fistulas and grafts
It is very uncertain whether continuous Infusion changes patency at 30 days compared with pulse spray technique (very low certainty).
1 finding from 1 review
Patency at 30 days · thrombosed haemodialysis arteriovenous fistulas and grafts
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Patency at 30 days · thrombosed haemodialysis arteriovenous fistulas and grafts
It is very uncertain whether surgical thrombectomy changes patency at 30 days compared with different types of endovascular interventions (very low certainty).
1 finding from 1 review
Patency at 30 days · thrombosed haemodialysis arteriovenous fistulas and grafts
It is very uncertain whether surgical thrombectomy changes patency at 30 days compared with mechanical thrombectomy (very low certainty).
1 finding from 1 review
Duration of hospital admission (days) · children with medical complexity
1 finding from 1 review
Intervention not reported
Death from bleeding complications (up to 30 days · vascular surgery patients who undergo creation of an anastomosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Postoperative bleeding (up to 30 days · vascular surgery patients who undergo creation of an anastomosis
The intervention showed no clear difference in postoperative bleeding (up to 30 days (low certainty).
1 finding from 1 review
Intervention not reported
Unplanned return to the operating room (up to 30 days · vascular surgery patients who undergo creation of an anastomosis
The intervention showed no clear difference in unplanned return to the operating room (up to 30 days (low certainty).
1 finding from 1 review
Frequency of crisis (number of pain days) · sickle cell disease
N‐acetylcysteine (1200 mg) showed no clear difference in frequency of crisis (number of pain days) compared with placebo (low certainty).
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · sickle cell disease
N‐acetylcysteine (1200 mg) showed no clear difference in severity of pain (maximum pain intensity on pain days) compared with placebo (low certainty).
1 finding from 1 review
Frequency of hospitalization (number of days in hospital) · sickle cell disease
It is very uncertain whether L‐arginine changes frequency of hospitalization (number of days in hospital) compared with placebo (very low certainty).
1 finding from 1 review